[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioStocks Avatar @BioStocks Bio Stocks™

Bio Stocks™ posts on X about $barcl, $acad, $btc, $biib the most. They currently have XXXXXX followers and 3360 posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence finance stocks cryptocurrencies countries vc firms currencies

Social topic influence $barcl #27, $acad #9, $btc, $biib #2, $bmy #73, $rxrx, $absi, alzheimers, $60m #24, $amgn #39

Top assets mentioned Acadia Pharmaceuticals Inc. (ACAD) Bitcoin (BTC) Biogen Inc (BIIB) Bristol-Myers Squibb Co (BMY) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Amgen, Inc. (AMGN) Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Mineralys Therapeutics, Inc. Common Stock (MLYS) Cytokinetics Inc. (CYTK) Synthetify (SNY) Sarepta Therapeutics, Inc. (SRPT) Curate (XCUR) Apogee Therapeutics, Inc. Common Stock (APGE) Viking Therapeutics, Inc (VKTX) WW International, Inc. Common Stock (WW) Hims & Hers Health, Inc. (HIMS) iShares BTC Trust (IBIT) Grayscale BTC ETF (GBTC) Deutsche Bank Aktiengesellschaft (DB) SPDR GOLD ETF (GLD) Huma Finance (HUMA) AstraZeneca PLC (AZN) GoodRx Holdings, Inc. Class A Common Stock (GDRX) Intellia Therapeutics, Inc (NTLA) Ethereum (ETH) JPMorgan Chase (JPM) Dyne Therapeutics, Inc. Common Stock (DYN) Pfizer, Inc. (PFE) Gilead Sciences, Inc. (GILD)

Top Social Posts #

Top posts by engagements in the last XX hours

"Bristol Myers Takeda to pool data for AI-based drug discovery. $BMY $TAK $RXRX $ABSI"
X Link @BioStocks 2025-10-01T12:04Z 69.8K followers, 8051 engagements

"$GUTS Announces Potent Preclinical Results from RJVA-002 a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity. RJVA-002 achieved XX% weight loss at five weeks in a translational obesity model; weight loss not yet plateaued"
X Link @BioStocks 2025-10-07T11:01Z 69.8K followers, 10.7K engagements

"$CDTX initiated with an Overweight at JPMorgan. PT $200"
X Link @BioStocks 2025-10-10T10:17Z 69.8K followers, 5902 engagements

"$ACAD halted"
X Link @BioStocks 2025-09-24T10:56Z 69.8K followers, 3712 engagements

"$MLYS Completes Enrollment in Phase X EXPLORE-OSA Trial of Lorundrostat in Obstructive Sleep Apnea and Hypertension. Topline data expected in Q1"
X Link @BioStocks 2025-09-30T12:02Z 69.8K followers, 3392 engagements

"$OCUL PT raised to $XX at Baird"
X Link @BioStocks 2025-10-03T11:47Z 69.8K followers, 5286 engagements

"$BMY Anti-MTBR-Tau-Targeting Antibody BMS-986446 Granted Fast Track Designation for the Treatment of Alzheimers Disease"
X Link @BioStocks 2025-10-01T11:40Z 69.8K followers, 5511 engagements

"$ENGN $60M PIPE 6.75M shares at $8.90/share Deep Track Capital Cormorant Asset Management Forbion OrbiMed Sphera Healthcare Vestal Point Capital and Venrock Healthcare Capital"
X Link @BioStocks 2024-10-25T12:02Z 69.8K followers, 4409 engagements

"$AMGN announced the launch of AmgenNow a new direct-to-patient program starting with Repatha. Eligible Patients Can Access Repatha at Nearly XX% Discount from the List Price"
X Link @BioStocks 2025-10-06T13:03Z 69.8K followers, 3730 engagements

"$CYTK PT raised to $XX at Barclays"
X Link @BioStocks 2025-10-06T10:50Z 69.8K followers, 13.6K engagements

"$SNY expands patient affordability program by offering access to all its insulins for $XX per month in the US"
X Link @BioStocks 2025-09-26T12:14Z 69.8K followers, 3381 engagements

"$PGEN Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS. XX out of XX complete responders (83%) demonstrate continued complete response with median follow-up of XX months"
X Link @BioStocks 2025-10-13T11:03Z 69.8K followers, 7986 engagements

"$SRPT to Present New Data from its Neuromuscular Portfolio at #WMS25"
X Link @BioStocks 2025-10-03T12:31Z 69.8K followers, 8924 engagements

"$XCUR Completes the Last Patient Last Visit in Phase X Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant. Topline data Q4"
X Link @BioStocks 2025-08-02T14:26Z 69.8K followers, 3576 engagements

"$CRVO Announces New Data from Phase 2b Trial Demonstrating Neflamapimod's Potential as a Treatment for Dementia with Lewy Bodies"
X Link @BioStocks 2025-10-08T11:02Z 69.8K followers, 3967 engagements

"$APGE offering closed. $345M raised"
X Link @BioStocks 2025-10-10T20:14Z 69.8K followers, 4741 engagements

"$PEPG PT raised to $X at BofA. Maintains Underperform rating"
X Link @BioStocks 2025-10-09T11:29Z 69.8K followers, 4483 engagements

"$NVO plans online launch for obesity pill once approved. $LLY $VKTX $HIMS $WW Novo is exploring a subscription-style model and expects to start selling the drug in early 2026"
X Link @BioStocks 2025-10-04T16:15Z 69.8K followers, 5850 engagements

"Both #Bitcoin and Gold to likely feature on central bank balance sheets by 2030 - Deutsche Bank. $BTC $GLD $IBIT $GBTC"
X Link @BioStocks 2025-10-07T21:19Z 69.8K followers, 3698 engagements

"$JBIO Announces JADE201 a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases. + $135M PIPE"
X Link @BioStocks 2025-10-07T11:07Z 69.8K followers, 5520 engagements

"$HUMA $60M direct offering priced at $2.11"
X Link @BioStocks 2025-10-07T13:05Z 69.8K followers, 4223 engagements

"$AZN signs $555M AI deal to develop gene-editing therapies with Algen Biotechnologies. $RXRX $ABSI"
X Link @BioStocks 2025-10-06T10:14Z 69.8K followers, 5327 engagements

"$MNKD to acquire $SCPH Upfront cash payment of $5.35/share plus CVR"
X Link @BioStocks 2025-08-25T11:32Z 69.8K followers, 12.6K engagements

"$GDRX And $AMGN Partner To Offer Repatha Nationwide For $239"
X Link @BioStocks 2025-10-06T13:29Z 69.8K followers, 10.6K engagements

"$ACAD Carbetocin did not demonstrate a statistically significant improvement over placebo on the studys primary endpoint nor was there separation from placebo on any secondary endpoint. 😬"
X Link @BioStocks 2025-09-24T11:04Z 69.8K followers, 8073 engagements

"$TSHA Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at #CNS25"
X Link @BioStocks 2025-10-09T12:03Z 69.8K followers, 4274 engagements

"$NTLA upgraded to Outperform at Citizens JMP. PT $33"
X Link @BioStocks 2025-10-06T11:18Z 69.8K followers, 4163 engagements

"Oh man Talk about bad timing. 😬 $TVRD covg initiated with an Overweight at Barclays. PT $61"
X Link @BioStocks 2025-10-13T13:34Z 69.8K followers, 10.6K engagements

"$OVID announces positive topline results from Phase X study of OV329 a next generation GABA aminotransferase (GABA-AT) inhibitor being developed for drug-resistant epilepsies"
X Link @BioStocks 2025-10-03T11:02Z 69.8K followers, 8988 engagements

"$NVO Halts Cell Therapy Work on Diabetes to Cut Costs Almost all of the division's about XXX employees are expected to be laid off"
X Link @BioStocks 2025-10-10T20:10Z 69.8K followers, 6905 engagements

"Cryptos record selloff - bets worth more than $19B have been wiped out and more than XXX million traders liquidated. #CryptoCrash $BTC"
X Link @BioStocks 2025-10-11T23:15Z 69.8K followers, 1466 engagements

"$PLRX $ALLO downgraded to Underweight at JP Morgan"
X Link @BioStocks 2025-10-10T11:50Z 69.8K followers, 4185 engagements

"Cryptos record selloff - more than XXX million traders liquidated. #CryptoCrash $BTC $ETH"
X Link @BioStocks 2025-10-11T23:24Z 69.8K followers, 5111 engagements

"$BIIB and Eisai Announce U.S. Availability of LEQEMBI IQLIK Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease"
X Link @BioStocks 2025-10-06T20:32Z 69.8K followers, 4539 engagements

"$SYRE prices $275M offering. 14.86M shares at $18.50/share"
X Link @BioStocks 2025-10-14T01:09Z 69.8K followers, 5194 engagements

"$ABVX initiated with an Overweight at Barclays. PT $142"
X Link @BioStocks 2025-10-13T10:00Z 69.8K followers, 6704 engagements

"$CRVS initiated with an Overweight at Barclays. PT $16"
X Link @BioStocks 2025-10-13T10:07Z 69.8K followers, 12.9K engagements

"$BIIB LEQEMBI IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China"
X Link @BioStocks 2025-09-28T23:45Z 69.8K followers, 5710 engagements

"JPMorgan to Invest $10B in U.S. Co's Critical to National Security. $JPM It has become painfully clear that the United States has allowed itself to become too reliant on unreliable sources of critical minerals products and manufacturing all of which are essential for our national security" Jamie Dimon"
X Link @BioStocks 2025-10-13T10:21Z 69.8K followers, 6743 engagements

"$IMAB Completes Enrollment in Phase 1b Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers. Topline data expected in Q1"
X Link @BioStocks 2025-08-11T11:12Z 69.8K followers, 3752 engagements

"$LLY to invest over $X billion in India"
X Link @BioStocks 2025-10-06T12:09Z 69.8K followers, 3462 engagements

"$BIIB LEQEMBI IQLIK Subcutaneous Autoinjector Named to TIMEs Best Inventions of 2025"
X Link @BioStocks 2025-10-14T00:11Z 69.8K followers, 3817 engagements

"$OVID initiated with an Outperform at Oppenheimer. PT $7"
X Link @BioStocks 2025-10-08T22:18Z 69.8K followers, 18.8K engagements

"$DYN Announces FDA Breakthrough Therapy Designation for DYNE-251 in DMD"
X Link @BioStocks 2025-08-04T11:32Z 69.8K followers, 3704 engagements

"$ACAD Phase X COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary Endpoint"
X Link @BioStocks 2025-09-24T11:00Z 69.8K followers, 18.7K engagements

"$PFE positive topline data from Phase X HER2CLIMB-05 trial of first-line combination therapy with the tyrosine kinase inhibitor TUKYSA in patients with HER2+ metastatic breast cancer"
X Link @BioStocks 2025-10-14T10:51Z 69.8K followers, 4535 engagements

"$RCUS Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed XXXX Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase X EDGE-Gastric Study. $GILD"
X Link @BioStocks 2025-10-12T22:47Z 69.8K followers, 13.8K engagements